Evidence map›Paper›PMID 28900642›Full record

ArticleChemical communications (Cambridge, England)2017

A mutation-resistant deoxyribozyme OR gate for highly selective detection of viral nucleic acids.

Ola Kamar, Sin-Cih Sun, Chieh-Hua Lin, Wan-Yu Chung, Min-Shi Lee, Yu-Chieh Liao, Dmitry M Kolpashchikov, Min-Chieh Chuang

Open access · greenAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Catalyst-based biomolecular logic gates.Catalysts (Basel, Switzerland) · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 5 countries.

Ola KamarChemistry Department, University of Central Florida, Orlando, 32816, Florida, USA. dmitry.kolpashchikov@ucf.edu.
Sin-Cih Sun
Chieh-Hua Lin
Wan-Yu Chung
Min-Shi Lee
Yu-Chieh Liao
Dmitry M Kolpashchikov
Min-Chieh Chuang
National Health Research Institutes · TWTunghai University · TWUniversity of Central Florida · US

Funding

Deoxyribozyme sensor-based diagnostics for Mycobacterium tuberculosisR15AI103880 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI KOLPASHCHIKOV, DMITRY MIKHAYLOVICH · 2013 to 2013
$430k
NIAID NIH HHS R15 AI103880
6 · The paper itself

Abstract

Highly selective probes hybridize only to fully complementary DNA or RNA sequences and, therefore, often fail to recognize mutated viral genomes. Here we designed a probe that possesses two seemingly incompatible properties: it tolerates some point mutations in genome, while it remains selective towards others. An OR deoxyribozyme logic gate was designed to fluorescently report the sequences of enterovirus 71 (EV71) covering ∼90% of all known EV71 strains. Importantly, sequences of closely related coxsackieviruses that differed by single nucleotides were reliably differentiated in 7 out of 8 cases.

Indexed as

MutationOptical ImagingDNA, CatalyticDNA, ViralEnterovirus A, HumanFluorescent DyesDNA, CatalyticDNA, ViralFluorescent Dyes

Identifiers

PMID28900642
PMCPMC5645154
OpenAlexW2752906144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.